Related Experiment Videos
Antenatal therapies and the developing brain
Insights
Antenatal steroids and magnesium sulfate use in preterm birth risk pregnancies show mixed effects on infant brain development. Multiple doses may harm neurodevelopment, while single doses offer benefits, necessitating careful consideration of timing and dosage.
Area of Science:
- Perinatology
- Neuroscience
- Developmental Pediatrics
Background:
- Infants born very low birthweight (VLBW) face significant neurodevelopmental risks.
- Antenatal therapies are used to mitigate risks associated with preterm delivery.
- Understanding the impact of these therapies on the developing brain is critical for long-term outcomes.
Purpose of the Study:
- To review basic science and human studies on antenatal steroids and magnesium sulfate.
- To examine the effects of these agents on the developing brain in pregnancies at risk of preterm delivery.
- To elucidate mechanisms of neuroprotection and neurotoxicity.
Main Methods:
- Review of experimental animal literature.
- Analysis of clinical studies in human pregnancies.
- Examination of data on single versus multiple doses and timing of administration.
Main Results:
- Short-term benefits of a single course of antenatal steroids are documented.
- Animal studies suggest detrimental neurodevelopmental effects from multiple antenatal steroid doses.
- Clinical studies indicate potential negative impacts on head and brain growth with repeat antenatal steroid doses.
- Data on magnesium sulfate (MgSO4) effects on neurodevelopment are mixed, showing both beneficial and neutral outcomes.
Conclusions:
- The impact of antenatal therapies on infant neurodevelopment requires careful evaluation.
- Dosing frequency and timing are crucial factors influencing neurodevelopmental outcomes.
- Further research is needed to optimize the use of antenatal steroids and magnesium sulfate for improved long-term neurodevelopmental sequelae in VLBW infants.
Abstract:
This chapter presents a review of basic science and human studies of two commonly used pharmacologic agents (antenatal steroids and magnesium sulfate), in pregnancies at risk of preterm delivery, and examines the effects of these therapies on the developing brain. Very low birthweight (VLBW) infants are known to be at risk of both short-term and long-term neurodevelopmental sequelae; therefore, an understanding of the mechanisms contributing to both neuroprotective and neurotoxic effects of antenatal therapies on the immature brain and potential effects on long-term outcome are critical. Although the short-term beneficial effects of a single course of antenatal steroids are well documented, the experimental animal literature suggests detrimental effects on neurodevelopment of multiple doses. In addition, clinical studies of repeat doses suggest a negative impact on head and brain growth. The animal and human data on the effects of MgSO(4)are also mixed with both beneficial effects or no effects on neurodevelopment. This review will discuss the potential impact of single versus multiple doses and timing of doses on the brain.